Year: 2022-23

Company: Rousselot BV

Liaison(s): Jeff Daelman, Sarah Steenhaut

Rousselot Biomedical (RLT) would like to successfully break into the biomedical devices market, providing collagen-based solutions for biomedical applications. RLT wants to better understand the current US market of biomedical device companies working with biomaterials (gelatin and beyond) and grasp the future market conditions. This exercise should inform Rousselot’s strategy and commercial development by identifying growth opportunities for RLT in the US biomedical market.